Loading…
Loading…
| # | Company | Status |
|---|---|---|
| 1 | Admitted-Finance | Admitted-Finance |
| 2 | Admitted-Finance CIPLA HOUSE PENINSULA BUSINESS PARK GANPATRAO KADAM MARG LOWER PAREL MUMBAI MAHARASHTRA 400013 | MUMBAI | MAHARASHTRA | 400013 | Admitted-Finance |
| 3 | Admitted-Finance PLOT NO 2117 A 2 PHASE II II G I D C VAPI GUJARAT INDIA 396195 | VAPI | VALSAD | GUJARAT | 396195 | Admitted-Finance |
| 4 | Admitted-Finance C 21 22 23 SECTOR 3 NOIDA GB NAGAR UP UNICURE INDIA LTD NOIDA SECTOR 3 GAUTAM BUDH NAGAR GAUTAM BUDDHA NAGAR UTTAR PRADESH 201301 | GAUTAM BUDDHA NAGAR | UTTAR PRADESH | 201301 | Admitted-Finance |
Tender Value
Refer Docs
Closing Date
12 Dec 2024, 4:30 pmClosed
Managing Director PHSC
Managing Director, Punjab Health Systems Corporation, Second Floor, E-Block, Punjab School Education Board Complex, Phase-8, Mohali
Anti-retroviral Drugs
2024_DHFW_129837_1
ETender/PHSC/Proc/2024/178
Open Tender
Medicines
Item Wise
180 days
SAS Nagar
As per DNIT
3 documents required · 3 mandatory
₹500
Exempted
Committee Room of Punjab Health Systems Corporatio
29 Jan 2025
14 Nov 2024
13 Dec 2024
14 Nov 2024
12 Dec 2024
30 Nov 2024
21 Nov 2024
Antiretroviral Drugs
Tenofovir 300mg+ Lamivudine 300mg+Dolutegravir 50mg/tablet
Zidovudine 300mg+ Lamivudine 150 mg
Dolutegravir 50mg/tablet
Abacavir 600mg+Lamivudine 300 mg
Atazanavir 300mg and Ritonavir 100mg/Tablet
Ritonavir IP 100mg-Tablet
Darunavir IP 100mg-Tablet
Abacavir 60 mg+ Lamivudine 30 mg/Tablets
Zidovudine 60 mg+ Lamivudine 30 mg
Doultegravir 10 mg ( Peadiatric)
Syp Nevirapine
Syp. Zidovudine
Aurobindo Pharma Ltd. (BID ID -600389)
MicronPharmaceuticals (BID ID -600636)
UNICURE INDIA LIMITED (BID ID -602867)
UNICURE INDIA LIMITED
Cipla ltd
stage.html
html • 0.03 MB
tech_eval.pdf
boq_comp_chart.xlsx
xlsx
Tap a document below to read it instantly. You can also download everything as a ZIP if you prefer.
details.html
html • 0.03 MB
Download all tender documents and submit your bid
Disclaimer: TenderKart has made every reasonable effort to ensure that the information on this page is accurate and authentic, however it cannot be held liable for any third-party claims or losses or any damages. TenderKart makes no warranty, expressed or implied, as to the results obtained from the use of this information. If you notice any error or omission, please let us know at .